During the past decade, Hosp. Clinico de Barcelona CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hosp. Clinico de Barcelona CRS" #1 collaborator was "Chiron Corporation" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hosp. Clinico de Barcelona CRS" are "HIV Infections" (2 trials). Many other conditions were trialed in "Hosp. Clinico de Barcelona CRS" in a lesser frequency.

Most popular intervention types in "Hosp. Clinico de Barcelona CRS" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "IL-2" (1 trials) and "Recombinant interleukin-2 (rIL-2)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hosp. Clinico de Barcelona CRS" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hosp. Clinico de Barcelona CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hosp. Clinico de Barcelona CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hosp. Clinico de Barcelona CRS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".